GPC-3 CAR T cells

CAR T cells targeting glypican-3 (GPC-3) · Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GPC-3 CAR T cells, covering 2026-01-28 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma [Phase 1]